KR20120106475A - Functional cosmetic composition including herb medicine extract - Google Patents

Functional cosmetic composition including herb medicine extract Download PDF

Info

Publication number
KR20120106475A
KR20120106475A KR1020110024607A KR20110024607A KR20120106475A KR 20120106475 A KR20120106475 A KR 20120106475A KR 1020110024607 A KR1020110024607 A KR 1020110024607A KR 20110024607 A KR20110024607 A KR 20110024607A KR 20120106475 A KR20120106475 A KR 20120106475A
Authority
KR
South Korea
Prior art keywords
cosmetic composition
herbal medicine
functional cosmetic
extract
herbal
Prior art date
Application number
KR1020110024607A
Other languages
Korean (ko)
Other versions
KR101418826B1 (en
Inventor
한규수
전찬규
Original Assignee
주식회사 제주자연
한규수
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 제주자연, 한규수 filed Critical 주식회사 제주자연
Priority to KR1020110024607A priority Critical patent/KR101418826B1/en
Publication of KR20120106475A publication Critical patent/KR20120106475A/en
Application granted granted Critical
Publication of KR101418826B1 publication Critical patent/KR101418826B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: A functional cosmetic composition containing crude drug extract including Chamaecyparis obtuse(Siebold & Zucc.) ENDL. is provided to ensure skin moisturizing and whitening effects and to reduce pore size. CONSTITUTION: A functional cosmetic composition contains crude drug extract including 40-60 wt% of Chamaecyparis obtuse(Siebold & Zucc.) ENDL. The crude drug extract further contains 5-15 wt% of Chrysanthemum morifolium, 10-30 wt% of ginseng, and 10-30 wt% of Rehmanniae Radix. The crude drug extract also contains 1-5 wt% of Scutellariae Radix. The functional cosmetic composition contains 1-30 wt% of crude drug extract. The cosmetic composition is a lotion, nutrition cream, massage cream, essence, gel, serum, pack, powder, external use skin ointment, suspension, emulsion, or spray.

Description

생약재 추출물 함유 기능성 화장품 조성물{FUNCTIONAL COSMETIC COMPOSITION INCLUDING HERB MEDICINE EXTRACT}Functional cosmetic composition containing herbal extracts {FUNCTIONAL COSMETIC COMPOSITION INCLUDING HERB MEDICINE EXTRACT}

본 발명은 생약재 추출물 함유 기능성 화장품 조성물에 관한 것으로, 보다 상세하게는 인체 피부에 수분을 공급하고 모공크기를 감소시키며 각질 및 주름을 완화시키고 색소침착을 억제하는 효과를 갖는 생약재 추출물 함유 기능성 화장품 조성물에 관한 것이다. The present invention relates to a functional cosmetic composition containing herbal extracts, and more particularly, to a functional cosmetic composition containing herbal medicine extracts having the effect of moisturizing human skin, reducing pore size, relieving dead skin cells and wrinkles, and inhibiting pigmentation. It is about.

최근 피부에 대한 관심이 높아짐에 따라 다양한 기능을 갖는 기능성 화장품에 대한 연구가 계속되고 있다. 피부에 수분을 공급하기 위한 화장품, 모공의 크기를 줄이기 위한 화장품, 피부 각질을 제거하기 위한 화장품, 주름을 완화시키기 위한 화장품, 미백기능을 갖는 화장품 등 다양한 기능을 가진 화장품들이 출시되고 있다.Recently, as the interest on the skin increases, researches on functional cosmetics having various functions continue. Cosmetics with various functions such as cosmetics to moisturize the skin, cosmetics to reduce the size of pores, cosmetics to remove dead skin cells, cosmetics to relieve wrinkles, and cosmetics with a whitening function are being released.

각 화장품들은 목적하는 효능을 가지므로 각 효능을 만족시키기 위하여 수 종의 화장품을 이용해야 하는 번거로움이 있다. Since each cosmetic has a desired effect, it is troublesome to use several cosmetics to satisfy each effect.

특히 화학적 성분의 화장품은 피부에 자극이 많은바 피부에 자극이 적은 천연식물에서 상기한 효능을 갖는 물질 개발이 이루어지고 있다. In particular, the cosmetics of the chemical component has a lot of irritation on the skin has been developed a substance having the above-mentioned effect in the natural plant with less irritation on the skin.

이에 본 발명의 발명자는 피부에 다기능의 효과를 달성할 수 있는 물질을 연구하던 중 생약재 성분 중 편백나무를 필수 포함하고 국화, 인삼, 지황, 황금 등을 선택 적의 혼합하여 피부에 여러가지 우수한 효과를 가짐을 발견하고 본 발명의 화장품 조성물을 개발하여 본 발명에 이르렀다. Therefore, the inventor of the present invention, while researching a substance that can achieve a multi-functional effect on the skin includes a cypress wood essential ingredient of the herbal medicine and has a variety of excellent effects on the skin by selectively mixing chrysanthemum, ginseng, sulfur, golden, etc. The present invention was found by developing the cosmetic composition of the present invention.

본 발명의 목적은 인체 피부에 수분을 공급하고 모공크기를 감소시키며 각질 및 주름을 완화시키며 색소침착을 억제하는 효과를 갖는 생약재 추출물 함유 기능성 화장품 조성물을 제공하는 것이다. An object of the present invention is to provide a functional cosmetic composition containing herbal extracts having the effect of moisturizing human skin, reducing pore size, relieving dead skin cells and wrinkles, and inhibiting pigmentation.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 편백나무로 이루어지는 생약재의 추출물을 함유하는 것을 특징으로 한다.Functional cosmetic composition containing the herbal medicine extract of the present invention is characterized in that it contains an extract of the herbal medicine made of cypress.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 상기 생약재에 국화가 더 포함되는 것을 특징으로 한다.Functional cosmetic composition containing the herbal extract of the present invention is characterized in that the herbal further comprises chrysanthemum.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 상기 생약재에 인삼 및 지황이 더 포함되는 것을 특징으로 한다.Functional cosmetic composition containing the herbal medicine extract of the present invention is characterized in that the herbal medicine further comprises ginseng and sulfur.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 상기 생약재가 생약재 총중량에 대하여 편백나무 40 내지 60 중량%, 국화 5 내지 15 중량%, 인삼 10 내지 30 중량%, 및 지황 10 내지 30 중량%로 이루어지는 것을 특징으로 한다.Functional cosmetic composition containing the herbal medicine extract of the present invention is characterized in that the herbal medicine comprises 40 to 60% by weight, 5 to 15% by weight of chrysanthemum, 10 to 30% by weight, ginseng and 10 to 30% by weight relative to the total weight of the herbal medicine It is done.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 생약재 총중량에 대하여 황금이 1 내지 5 중량% 더 포함되는 것을 특징으로 한다. Functional cosmetic composition containing the herbal extract of the present invention is characterized in that 1 to 5% by weight of gold is further included relative to the total weight of the herbal medicine.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 상기 생약재 추출물이 생약재를 수증기 증류법으로 추출하여 얻어지는 정유인 것을 특징으로 한다. Functional cosmetic composition containing the herbal extract of the present invention is characterized in that the herbal extract is an essential oil obtained by extracting the herbal medicine by steam distillation.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 생약재 추출물 함유 기능성 화장품 조성물 총중량에 대하여 1 내지 30 중량% 생약재 추출물이 함유되는 것을 특징으로 한다. The herbal medicine extract-containing functional cosmetic composition of the present invention is characterized in that it contains 1 to 30% by weight of the herbal medicine extract based on the total weight of the herbal medicine extract-containing functional cosmetic composition.

본 발명의 기능성 화장품 조성물은 편백나무 추출물를 함유함으로써 인체 피부에 수분을 공급하여 피부 보습력이 우수하고 색소침착을 억제하여 피부미백에 효과가 있을 뿐만 아니라 모공크기를 감소시키고 각질 및 주름을 완화시키는 효과가 있다. Functional cosmetic composition of the present invention by supplying the extract of the Cypress, moisture to the human skin is excellent skin moisturizing power and inhibits pigmentation is not only effective in skin whitening, but also reduce the pore size and relieve dead skin cells and wrinkles have.

또한, 본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 천연성분으로 이루어짐으로써 피부에 자극이 적고 피부를 윤택하게 하는 효과가 있다.In addition, the herbal cosmetic extract-containing functional cosmetic composition of the present invention is made of a natural component is less irritating to the skin and has the effect of making the skin smooth.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물은 편백나무로 이루어지는 생약재의 추출물을 함유하는 것을 특징으로 한다.Functional cosmetic composition containing the herbal medicine extract of the present invention is characterized in that it contains an extract of the herbal medicine made of cypress.

편백나무는 겉씨식물 구과목 측백나무과의 상록교목으로 피톤치드(pyhtoncide)를 다량 발생하는 것으로 알려져 있다. 피톤치드는 식물이 병원균에 저항하기 위해 방출 또는 분비하는 물질이다. Cypress is an evergreen tree of the genus Cypressaceae, known to produce large amounts of pyhtoncide. Phytoncide is a substance that plants release or secrete to resist pathogens.

피톤치드는 인체에 흡수가 잘 되고 흡수된 피톤치드는 세포에 활력을 주고 면역력을 높여 세포를 괴롭히고 있던 문제의 세균들을 죽이거나 몰아내는 역할을 한다. Phytoncide is well absorbed by the human body, and the absorbed phytoncide is responsible for killing or driving away the germs that are harassing the cell by boosting its vitality and boosting immunity.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 상기 생약재에 국화가 더 포함될 수 있다. In the functional cosmetic composition containing the herbal medicine extract of the present invention, chrysanthemum may be further included in the herbal medicine.

국화는 쌍떡잎식물 초롱꽃목 국화과의 여러해살이풀로 혈액순환을 돕고 노화를 억제하는 효과가 있다. Chrysanthemum is a perennial herb of the dicotyledon plant Campanula Asteraceae, which helps blood circulation and inhibits aging.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 상기 생약재에 인삼이 더 포함될 수 있다.In the functional cosmetic composition containing the herbal medicine extract of the present invention, ginseng may be further included in the herbal medicine.

인삼은 쌍떡잎식물 산형화목 두릅나무과의 여러해살이풀로 피부 재생과 노화를 억제하는 효과가 있다. Ginseng is a perennial herb of the dicotyledonous plant cultivars Armiaceae, which has the effect of inhibiting skin regeneration and aging.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 상기 생약재에 지황이 더 포함될 수 있다.In the herbal cosmetic extract-containing functional cosmetic composition of the present invention, the turmeric may be further included in the herbal medicine.

지황은 쌍떡잎식물 통화식물목 현삼과의 여러해살이풀로 혈행 촉진과 피부의 재생 기능을 돕고 피부 속 기능을 향상시켜 피부를 탄력있게 하는 효과가 있다. Jihwang is a perennial herb of dicotyledon and moss plant. It is effective for promoting blood circulation and regenerating the skin and improving the function in the skin to make the skin elastic.

특히 본 발명에서 인삼과 지황이 같이 사용됨으로써 인삼의 뜨거운 성질과 지황의 찬 성질이 중화되어 각 성분의 단점이 보완되는 잇점이 있다. In particular, by the use of ginseng and sulfur in the present invention, the hot properties of the ginseng and the cold properties of the sulfur is neutralized, there is an advantage that the disadvantages of each component is complemented.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 상기 생약재가 생약재 총중량에 대하여 편백나무 40 내지 60 중량%, 국화 5 내지 15 중량%, 인삼 10 내지 30 중량%, 및 지황 10 내지 30 중량%로 이루어지는 것이 바람직하다.In the functional cosmetic composition containing the herbal medicine extract of the present invention, the herbal medicine comprises 40 to 60% by weight of cypress, 5 to 15% by weight of chrysanthemum, 10 to 30% by weight of ginseng, and 10 to 30% by weight of turmeric It is preferable.

생약재의 상기 성분들이 상기한 함량으로 이루어질 때 본 발명의 생약재 추출물 함유 기능성 화장품 조성물의 보습 효과, 미백 효과, 색소침착 억제 효과, 모공크기 축소 효과, 각질 및 주름 완화 효과가 최적이 된다. When the above ingredients of the herbal medicine is made of the above-mentioned content, the moisturizing effect, whitening effect, pigmentation inhibiting effect, pore size reduction effect, keratin and wrinkle relief effect of the herbal medicine extract-containing functional cosmetic composition of the present invention is optimal.

또한, 본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 상기 생약재에 황금이 더 포함될 수 있다. In addition, in the herbal cosmetic extract-containing functional cosmetic composition of the present invention, gold may be further included in the herbal medicine.

황금(黃芩)은 쌍떡잎식물 통화식물목 꿀풀과의 여러해살이풀로, 항산화능, 자외선 보호능, 항균작용, 항염작용, 항알레르기, 미백효과, 피부노화방지 등의 효능이 있는 것으로 알려져 있다. Golden (黄 芩) is a perennial herb of the dicotyledon plant moss-flowered Lamiaceae, it is known to have antioxidant, UV protection, antibacterial, anti-inflammatory, anti-allergic, whitening effect, skin aging.

본 발명에서 황금은 생약재 총중량에 대하여 1 내지 5 중량% 포함되는 것이 바람직하다.In the present invention, gold is preferably included in an amount of 1 to 5% by weight based on the total weight of the herbal medicines.

황금의 함량이 생약재 총중량에 대하여 1 중량% 미만이면 항산화효과가 미비한 문제점이 있고, 황금의 함량이 생약재 총중량에 대하여 5 중량%를 초과하면 편백나무의 함량이 적어짐으로써 편백나무에 의한 효과가 적어지는 문제점이 있다.If the content of gold is less than 1% by weight relative to the total weight of herbal medicines, there is a problem that the antioxidant effect is insignificant. If the content of gold exceeds 5% by weight with respect to the total weight of herbal medicines, the content of cypress decreases, thereby reducing the effect of cypress trees. There is a problem.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 상기 생약재 추출물은 생약재를 수증기 증류법으로 추출하여 얻어지는 정유(essential oil)인 것을 특징으로 한다. In the functional cosmetic composition containing the herbal extract of the present invention, the herbal extract is characterized in that the essential oil (essential oil) obtained by extracting the herbal medicine by steam distillation.

본 발명의 생약재 추출물 함유 기능성 화장품 조성물에 있어서, 생약재 추출물 함량은 조성물 총중량에 대하여 1 내지 30 중량%인 것이 바람직하다.In the functional cosmetic composition containing the herbal extract of the present invention, the herbal extract content is preferably 1 to 30% by weight based on the total weight of the composition.

생약재 추출물 함량이 조성물 총중량에 대하여 1 중량% 미만이면 편백나무에 의한 효과가 미비한 문제점이 있고, 조성물 총중량에 대하여 30 중량%를 초과하면 화장품 제형 형성이 잘 되지 않는 문제점이 있다. If the herbal extract content is less than 1% by weight relative to the total weight of the composition, there is a problem that the effect of the cypress is inadequate, and if the content exceeds 30% by weight based on the total weight of the composition, there is a problem that the cosmetic formulation is not well formed.

보다 바람직한 생약재 추출물 함량은 화장품 조성물 총중량에 대하여 5 내지 25 중량%이다. More preferred herbal extract content is 5 to 25% by weight relative to the total weight of the cosmetic composition.

본 발명의 편백나무 함유 기능성 화장품 조성물은 화장수, 로션, 영양크림, 마사지크림, 에센스, 겔, 세럼, 팩, 파우더, 피부외용연고, 첩보제, 현탁액, 에멀젼, 스프레이 또는 미용액 등 다양한 형태의 제형으로 제조될 수 있다.The functional citrus-containing cosmetic composition of the present invention may be in various forms of formulation such as lotion, lotion, nourishing cream, massage cream, essence, gel, serum, pack, powder, external skin ointment, secret agent, suspension, emulsion, spray or cosmetic liquid. Can be prepared.

화장수, 로션, 영양크림, 마사지크림, 에센스, 겔, 세럼, 팩, 파우더, 피부외용연고, 첩보제, 현탁액, 에멀젼, 스프레이 또는 미용액 등은 본 기술분야에서 통상적으로 사용되는 성분으로 이루어진다. Facial lotions, lotions, nourishing creams, massage creams, essences, gels, serums, packs, powders, external ointments, splints, suspensions, emulsions, sprays or cosmetics and the like are made up of ingredients commonly used in the art.

이하, 하기 실시예 및 시험예를 통하여 본 발명의 생약재 함유 기능성 화장품 조성물을 보다 구체적으로 설명한다. Hereinafter, the herbal medicine-containing functional cosmetic composition of the present invention through the following examples and test examples in more detail.

<실시예 1> &Lt; Example 1 >

국내 남부지방에서 조림된 편백나무를 이용하였다. 깨끗이 세척한 편백나무 10㎏을 잘게 부수어 추출용기 안에 넣은 후 90~100℃의 수증기를 넣어 10~12시간 동안 증류시켜 휘발성 물질을 수집하였다. 수집된 휘발성 물질을 냉각장치로 이동시켜 냉각수를 주입하여 액화시켰다. 액화된 추출물은 상층에 정유와 하층에 수분으로 층분리되고 상층의 정유를 수득하였다. 수득된 정유 20g과 정제수 80g 및 카보폴 1g을 혼합하여 에센스를 제조하였다. A cypress planted in southern Korea was used. 10 kg of neatly washed cypresses were crushed and placed in an extraction container, followed by steaming at 90-100 ° C. for 10-12 hours to collect volatiles. The collected volatiles were transferred to a chiller and liquefied by injecting cooling water. The liquefied extract was separated into essential oils in the upper layer and water in the lower layer to obtain the essential oil of the upper layer. Essence was prepared by mixing 20 g of the obtained essential oil, 80 g of purified water, and 1 g of carbopol.

시험exam

실시예 1에서 제조된 화장수를 이용하여 다음의 시험을 실시하였다. The following test was done using the lotion manufactured in Example 1.

1) 시험대상: 피시험자는 25~45세의 여성 22명이었다.1) Subjects: There were 22 women aged 25 to 45 years.

2) 시험방법: 피부의 유,수분 보유량과 모공, 각질, 주름, 색소침착 등의 변화를 관찰하기 위하여 얼굴 우측 사백혈부근을 피부측정부위로 정하고 저녁 취침직전에 실시예 1에서 제조된 화장수를 도포하고 다음날 아침 세면을 통하여 제거하게 하였다. 피시험자는 기초화장과 색조화장은 이전대로 실시하였고 실험군을 실시예 1의 화장수가 도포되는 얼굴 우측 사백혈 부근으로 하고 대조군을 실시예 1의 화장수가 도포되지 않는 얼굴 좌측 사백혈 부근으로 하였다. 2) Test method: In order to observe changes in oil and moisture retention of skin and changes in pores, dead skin cells, wrinkles, pigmentation, etc., the area around the right side of the white blood cell was determined as a skin measurement site, and the lotion prepared in Example 1 was used immediately before bedtime in the evening. It was applied and removed through the toilet the next morning. The test subject was subjected to the basic makeup and the color makeup as before, and the experimental group was near the right side of the white leukemia on which the lotion of Example 1 was applied, and the control group was near the left side of the white leukemia on which the lotion of Example 1 was not applied.

평가는 실험 전과 실험 후의 1주마다 4주동안 평가하여 5차에 걸쳐 타각적 검사를 실시하였고 자각적 검사는 실험 종료 후 실시하였다. The evaluation was performed for four weeks before and after the experiment, and the subjective tests were conducted five times.

<시험예 1> 수분량 측정Test Example 1 Measurement of Water Content

수분측정기(Scalia Moisture Checker)를 이용하여 얼굴 좌ㆍ우 사백혈 부근의 수분량을 3번 측정한 후 평균값을 구하고 그 결과를 표 1에 나타내었다. Using a Scalia Moisture Checker (Scalia Moisture Checker) to measure the amount of water around the left and right sides of the white blood cells three times the average value was obtained and the results are shown in Table 1.

28미만(Grade1:20), 28~34(Grade 2:40), 35~39(Grade3:60), (Grade4:80), (Grade5:100)Less than 28 (Grade1: 20), 28-34 (Grade 2:40), 35-39 (Grade3: 60), (Grade4: 80), (Grade5: 100)

구분division 인원personnel 평균값medium 표준편차Standard Deviation t, pt, p 0주차Week 0 대조군Control group 2222 31.6431.64 4.294.29 .037
.971.037
.971 실험군Experimental group 2222 31.5931.59 3.953.95 1주차Week 1 대조군Control group 2222 31.6431.64 4.384.38 -.877
.385-.877
.385 실험군Experimental group 2222 32.7732.77 4.214.21 2주차2 parking 대조군Control group 2222 32.0032.00 4.344.34 -2.612*
.012-2.612 *
.012 실험군Experimental group 2222 35.6435.64 4.884.88 3주차3 parking 대조군Control group 2222 32.1432.14 4.754.75 -3.569**
.001-3.569 **
.001 실험군Experimental group 2222 37.2737.27 4.794.79 4주차4 weeks 대조군Control group 2222 32.0532.05 4.434.43 -4.711***
.000-4.711 ***
.000 실험군Experimental group 2222 38.8638.86 5.145.14 * : p<.05, ** : p<.01, *** : p<.001 *: p <.05, **: p <.01, ***: p <.001

표 1에 제시되어 있는 바와 같이, 실험군과 대조군 간의 수분량에 있어 0주차와 1주차에서는 통계적으로 유의한 차이를 보이고 있지 않았으며, 2주차에서는 t=-2.612로 유의수준 5%에서 차이를 보였고, 3주차에서는 유의수준 1%, 4주차에서는 유의수준 0.1%에서 차이를 보였다. 따라서, 실험군이 대조군에 비하여 수분량이 많음을 확인할 수 있었다. As shown in Table 1, there was no statistically significant difference between the experimental group and the control group at week 0 and week 1, and at week 2, t = -2.612. At week 3, the significance level was 1% and at week 4, the significance level was 0.1%. Therefore, it was confirmed that the experimental group has more moisture than the control group.

<시험예 2> 모공 측정 Test Example 2 Pore Measurement

고배율 디지털 피부 영상 카메라(주식회봄텍전자)를 이용하여 사백혈 부근에 올려놓고 화면을 찍어 확대한 후 제일 큰 모공 3개를 선정하여 지름을 측정한 후 평균값을 구하고 그 결과를 표 2에 나타내었다. Using a high magnification digital skin imaging camera (Bomb Tech Co., Ltd.), placed near the leukemia, the screen was taken and enlarged. The three largest pores were selected, the diameters were measured, and the average values were obtained. The results are shown in Table 2. .

0.1mm-0.2mm(Grade1:20), 0.2mm-0.4mm(Grade2:40), 0.4mm-0.6mm(Grade3:60), 0.6mm-0.8mm(Grade4:80), 0.8mm이상(Grade5:100)0.1mm-0.2mm (Grade1: 20), 0.2mm-0.4mm (Grade2: 40), 0.4mm-0.6mm (Grade3: 60), 0.6mm-0.8mm (Grade4: 80), 0.8mm or more (Grade5: 100)

구분division 인원personnel 평균값medium 표준편차Standard Deviation t, pt, p 0주차Week 0 대조군Control group 2222 .632.632 .176.176 -.263
.794-.263
.794 실험군Experimental group 2222 .645.645 .168.168 1주차Week 1 대조군Control group 2222 .609.609 .172.172 .801
.428.801
.428 실험군Experimental group 2222 .568.568 .167.167 2주차2 parking 대조군Control group 2222 .636.636 .159.159 4.403***
.0004.403 ***
.000 실험군Experimental group 2222 .405.405 .189.189 3주차3 parking 대조군Control group 2222 .614.614 .170.170 4.225***
.0004.225 ***
.000 실험군Experimental group 2222 .391.391 .180.180 4주차4 weeks 대조군Control group 2222 .609.609 .160.160 5.567***
.0005.567 ***
.000 실험군Experimental group 2222 .332.332 .170.170 *** : p<.001 ***: p <.001

표 2에 제시되어 있는 바와 같이, 실험군과 대조군 간의 모공 크기에 있어 0주차와 1주차에서는 통계적으로 유의한 차이를 보이고 있지 않았으며, 2주차에서는 t=4.403으로 유의수준 0.1%에서 차이를 보였고, 3주차에서는 유의수준 0.1%, 4주차에서는 유의수준 0.1%에서 차이를 보였다. 따라서, 실험군이 대조군에 비하여 모공크기가 작음을 확인할 수 있었다. As shown in Table 2, there was no statistically significant difference in pore size between the experimental and control groups at week 0 and week 1, and at week 2, t = 4.403, showing a difference at the significance level of 0.1%. At week 3, there was a difference of 0.1% in significance level, and at week 4, significance level was 0.1%. Therefore, the experimental group was confirmed that the pore size is smaller than the control group.

<시험예 3> 각질 측정 Test Example 3 Measurement of Keratin

사용전 각질테이프(주식회사봄텍전자)를 고배율 디지털 피부 영상 카메라에 대고 기준값을 설정한 후 좌우 사백혈에 붙여서 각질을 떼어낸 후 피부측정 디지털 카메라에 다시 부착하여 3번 측정한 후 평균값을 구하고 그 결과를 표 3에 나타내었다. Put the keratin tape (Bomtech Electronics Co., Ltd.) on the high magnification digital skin imaging camera before use, attach it to the left and right leukemias, remove the dead skin cells, attach them to the skin measurement digital camera, measure them three times, and find the average value. Is shown in Table 3.

0-70(Grade1:20), 71-150(Grade2:40), 151-270(Grade3:60), 271-450(Grade4:80), 451이상(Grade5:100)0-70 (Grade1: 20), 71-150 (Grade2: 40), 151-270 (Grade3: 60), 271-450 (Grade4: 80), 451 or more (Grade5: 100)

구분division 인원personnel 평균Average 표준편차Standard Deviation t, pt, p 0주차Week 0 대조군Control group 2222 360.64360.64 88.3488.34 .369
.714.369
.714 실험군Experimental group 2222 350.86350.86 87.5687.56 1주차Week 1 대조군Control group 2222 355.55355.55 88.3288.32 1.126
.2661.126
.266 실험군Experimental group 2222 325.73325.73 87.3087.30 2주차2 parking 대조군Control group 2222 351.50351.50 87.8887.88 1.989
.0531.989
.053 실험군Experimental group 2222 298.23298.23 89.7689.76 3주차3 parking 대조군Control group 2222 351.27351.27 85.9085.90 3.011**
.0043.011 **
.004 실험군Experimental group 2222 268.09268.09 97.0097.00 4주차4 weeks 대조군Control group 2222 350.59350.59 83.5783.57 4.010***
.0004.010 ***
.000 실험군Experimental group 2222 240.45240.45 98.0398.03 ** : p<.01, *** : p<.001 **: p <.01, ***: p <.001

표 3에 제시되어 있는 바와 같이, 실험군과 대조군 간의 각질량에 있어 0주차, 1주차, 2주차에서는 통계적으로 유의한 차이를 보이고 있지 않았으며, 3주차에서는 t=3.011로 유의수준 1%에서 차이를 보였고, 4주차에서는 유의수준 0.1%에서 차이를 보였다. 따라서, 실험군이 대조군에 비하여 각질량이 적음을 확인할 수 있었다. As shown in Table 3, there were no statistically significant differences in the angular mass between the experimental and control groups at week 0, week 1, and week 2, and at week 3, t = 3.011, indicating a difference of 1%. At week 4, there was a difference of 0.1% in significance level. Therefore, the experimental group was confirmed that the angular mass is less than the control group.

<시험예 4> 주름 측정 Test Example 4 Wrinkle Measurement

고배율 디지털 피부 영상 카메라를 좌우 사백혈 부위에 올려놓고 화면을 찍어 확대한 후 제일 큰 주름 3개를 선정하여 각 주름의 너비 간격을 측정한 후 평균값을 구하고 그 결과를 표 4에 나타내었다.The high magnification digital skin imaging camera was placed on the left and right leukemia sites and the screen was enlarged. Then, the three largest wrinkles were selected, the width intervals of each wrinkle were measured, and the average value was obtained. Table 4 shows the results.

0.0mm-0.1mm(Grade1:20), 0.1mm-0.2mm(Grade2:40), 0.2mm-0.3mm(Grade3:60), 0.3mm-0.5mm(Grade4:80), 0.5mm이상(Grade5:100)0.0mm-0.1mm (Grade1: 20), 0.1mm-0.2mm (Grade2: 40), 0.2mm-0.3mm (Grade3: 60), 0.3mm-0.5mm (Grade4: 80), 0.5mm or more (Grade5: 100)

구분division 인원personnel 평균Average 표준편차Standard Deviation t, pt, p 0주차Week 0 대조군Control group 2222 .436.436 .208.208 -.216
.830-.216
.830 실험군Experimental group 2222 .450.450 .211.211 1주차Week 1 대조군Control group 2222 .441.441 .209.209 -.073
.942-.073
.942 실험군Experimental group 2222 .445.445 .204.204 2주차2 parking 대조군Control group 2222 .450.450 .215.215 .488
.628.488
.628 실험군Experimental group 2222 .418.418 .217.217 3주차3 parking 대조군Control group 2222 .459.459 .238.238 .968
.339.968
.339 실험군Experimental group 2222 .391.391 .229.229 4주차4 weeks 대조군Control group 2222 .464.464 .238.238 1.558
.1271.558
.127 실험군Experimental group 2222 .355.355 .226.226

표 4에 제시되어 있는 바와 같이, 실험군과 대조군 간의 각질량에 있어 0주차, 1주차, 2주차, 3주차, 4주차 모두 통계적으로 유의한 차이를 보이지는 않았으나, 실험군이 대조군에 비하여 주름완화 효과가 있음을 확인할 수 있었다.As shown in Table 4, there was no statistically significant difference in the angular mass between the experimental group and the control group in the 0, 1, 2, 3, and 4 weeks, but the experimental group had the anti-wrinkle effect compared to the control group. It was confirmed that there is.

<시험예 5> 색소침착 Test Example 5 Pigmentation

고배율 디지털 피부 영상 카메라를 사백혈 부위에 올려놓고 화면을 찍어 확대한 후 피부 진단 시스템(Skin Diagnosis System)(주식회사봄텍전자)에 내장되어 있는 색소침착 견본들과 비교하여 그와 유사한 상태의 샘플을 선정하여 그 정도를 측정하고 그 결과를 표 5에 나타내었다.A high magnification digital skin imaging camera is placed on the leukemia area, the screen is taken and enlarged, and a sample of a similar state is selected by comparing with the pigmentation samples embedded in the Skin Diagnosis System. The degree was measured and the results are shown in Table 5.

견본샘플의 정도 - 약간있음1(Grade0:0), 약간있음2(Grade1:0), 약간있음3(Grade2:10), 약간있음4(Grade3:20), 약간심함1(Grade4:30), 약간심함2(Grade5:40), 약간심함3(Grade6:50), 약간심함4(Grade7:60), 매우심함1(Grade8:70), 매우심함2(Grade9:80), 매우심함3(Grade10:90), 매우심함4(Grade11:100)Grade 3: Grade 2: 10, Grade 3: 20, Grade 4: 30, Grade 1: 0, Grade 2: Grade 5: 40, Grade 6: 50, Grade 7: 60, Grade 8: 70, Grade 9: 80, Grade 10 : 90), very severe 4 (Grade 11: 100)

구분division 인원personnel 평균Average 표준편차Standard Deviation t, pt, p 0주차Week 0 대조군Control group 2222 5.145.14 2.532.53 .124
.902.124
.902 실험군Experimental group 2222 5.055.05 2.342.34 1주차Week 1 대조군Control group 2222 5.185.18 2.632.63 .359
.722.359
.722 실험군Experimental group 2222 4.914.91 2.412.41 2주차2 parking 대조군Control group 2222 5.275.27 2.552.55 1.007
.3201.007
.320 실험군Experimental group 2222 4.504.50 2.542.54 3주차3 parking 대조군Control group 2222 5.365.36 2.682.68 1.724
.0921.724
.092 실험군Experimental group 2222 4.004.00 2.562.56 4주차4 weeks 대조군Control group 2222 5.505.50 2.722.72 2.229*
.0312.229 *
.031 실험군Experimental group 2222 3.773.77 2.412.41 * : p<.05 *: p <.05

표 5에 제시되어 있는 바와 같이, 실험군과 대조군 간의 색소침착도에 있어 0주차, 1주차, 2주차, 3주차에서는 통계적으로 유의한 차이를 보이고 있지 않았으며, 4주차에서는 t=2.229로 유의수준 5%에서 차이를 보였다. 따라서, 실험군에서는 시간이 지남에 따라 색소침착도가 떨어짐을 확인할 수 있었다.As shown in Table 5, there was no statistically significant difference in pigmentation degree between the experimental group and the control group at week 0, week 1, week 2, and week 3, and at week 4, t = 2.229. The difference was 5%. Therefore, in the experimental group it was confirmed that the pigmentation deterioration over time.

<시험예 6> 관능평가 Test Example 6 Sensory Evaluation

4주간의 실험을 마치고 실시예 1에서 제조된 화장수의 관능평가를 설문실시하고 그 결과를 표 6에 나타내었다. After 4 weeks of experiment, the sensory evaluation of the lotion prepared in Example 1 was conducted and the results are shown in Table 6.

구 분division 인원(명)Number of people 비율(%)ratio(%) 피부자극느낌Skin irritation feeling 심한 자극감Severe irritation 1One 4.54.5 자극감 있음Irritating 55 22.722.7 자극감 없음No irritation 1616 72.772.7 피부 윤택감Skin luster 변화없음No change 55 22.722.7 조금 윤택A little moisture 1010 45.545.5 많이 윤택A lot of moisture 77 31.831.8 피부 보습력Skin moisture 변화없음No change 33 13.613.6 촉촉하고 부드러워짐Moist and soft 1919 86.486.4 피부 미백정도Skin whitening 변화없음No change 1010 45.545.5 엷어지면서 호전Improve thinning 1212 54.554.5 피부 주름정도Skin wrinkles 변화없음No change 55 22.722.7 주름이 개선Wrinkle improvement 1717 77.377.3 TotalTotal 2222 100.0100.0

표 6에 나타나 있는 바와 같이, 피부자극느낌에서는 자극감 없음이 72.7%로 가장 많았으며, 자극감 있음, 심한 자극감의 순으로 나타났다. 피부 윤택감에서는 조금 윤택이 45.5%로 가장 많았고, 많이 윤택도 31.8%로 높게 나타났다. 피부 보습력에서는 촉촉하고 부드러워짐이 86.4%로 가장 높게 나타났다. 피부 미백 정도에서는 엷어지면서 호전이 54.5%, 변화없음이 45.5%로 나타났다. 피부 주름 정도에서는 주름이 개선이 77.3%, 변화없음이 22.7%로 나타났다. As shown in Table 6, the most irritating feeling of skin irritation was the most irritating (72.7%), followed by stimulus, severe irritation. In skin shine, a little shine was the highest at 45.5% and a lot of shine was also high at 31.8%. In moisturizing skin, the most moist and soft was 86.4%. At skin whitening, the result of thinning was 54.5% and no change was 45.5%. In the degree of skin wrinkles, wrinkles improved 77.3% and no change 22.7%.

따라서 실시예 1의 화장수는 피부에 자극을 주지 않으면서 피부에 윤택과 보습을 부여하고 미백 및 주름완화에 효과가 있음을 확인할 수 있었다. Therefore, it was confirmed that the lotion of Example 1 gives moisture and moisturizing to the skin without irritating the skin and is effective in whitening and wrinkle relief.

이상에서 본 발명의 구체예가 제시되어 있지만 본 발명이 상기에 한정되는 것은 아니며 본 발명의 기술 사상 범위 내에서 다양하게 변형 가능하고 이러한 변형은 하기한 본 발명의 청구범위에 속한다 할 것이다.Specific embodiments of the present invention have been presented above, but the present invention is not limited to the above, and various modifications can be made within the technical spirit of the present invention, and such modifications will belong to the following claims.

Claims (8)

편백나무로 이루어지는 생약재의 추출물을 함유하는 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.A herbal cosmetic extract-containing functional cosmetic composition comprising an extract of a herbal medicine consisting of cypress. 청구항 1에 있어서,
상기 생약재에 국화가 더 포함되는 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.The method according to claim 1,
Functional cosmetic composition containing herbal medicine extract, characterized in that the herbal further comprises chrysanthemum. 청구항 2에 있어서,
상기 생약재에 인삼 및 지황이 더 포함되는 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물. The method according to claim 2,
The herbal medicine extract-containing functional cosmetic composition, characterized in that the herbal medicine further comprises ginseng and sulfur. 청구항 3에 있어서,
상기 생약재가 생약재 총중량에 대하여 편백나무 40 내지 60 중량%, 국화 5 내지 15 중량%, 인삼 10 내지 30 중량%, 및 지황 10 내지 30 중량%로 이루어지는 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.The method according to claim 3,
The herbal medicine is a functional cosmetic composition containing herbal medicine extract, characterized in that consisting of 40 to 60% by weight, 5 to 15% by weight of chrysanthemum, 10 to 30% by weight of ginseng, and 10 to 30% by weight of turmeric. 청구항 4에 있어서,
생약재 총중량에 대하여 황금이 1 내지 5 중량% 더 포함되는 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.The method of claim 4,
Functional cosmetic composition containing herbal medicine extract, characterized in that 1 to 5% by weight of gold based on the total weight of the herbal medicine. 청구항 1에 있어서,
상기 생약재 추출물은 생약재를 수증기 증류법으로 추출하여 얻어지는 정유인 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.The method according to claim 1,
The herbal medicine extract is a herbal medicine extract containing functional cosmetic composition, characterized in that the essential oil obtained by extracting the herbal medicine by steam distillation. 청구항 1에 있어서,
생약재 함유 기능성 화장품 조성물 총중량에 대하여 1 내지 30 중량% 생약재 추출물이 함유되는 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.The method according to claim 1,
Herbal medicine-containing functional cosmetic composition Herbal medicine extract-containing functional cosmetic composition, characterized in that containing 1 to 30% by weight of the herbal medicine extract based on the total weight. 청구항 1에 있어서,
상기 화장품 조성물의 제형이 화장수, 로션, 영양크림, 마사지크림, 에센스, 겔, 세럼, 팩, 파우더, 피부외용연고, 첩보제, 현탁액, 에멀젼, 스프레이 또는 미용액인 것을 특징으로 하는 생약재 추출물 함유 기능성 화장품 조성물.The method according to claim 1,
Functional cosmetic composition containing herbal extracts, characterized in that the formulation of the cosmetic composition is a lotion, lotion, nourishing cream, massage cream, essence, gel, serum, pack, powder, external skin ointment, eye patch, suspension, emulsion, spray or essence Composition.
KR1020110024607A 2011-03-18 2011-03-18 Cosmetic composition including herb medicine extract KR101418826B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020110024607A KR101418826B1 (en) 2011-03-18 2011-03-18 Cosmetic composition including herb medicine extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110024607A KR101418826B1 (en) 2011-03-18 2011-03-18 Cosmetic composition including herb medicine extract

Publications (2)

Publication Number Publication Date
KR20120106475A true KR20120106475A (en) 2012-09-26
KR101418826B1 KR101418826B1 (en) 2014-07-16

Family

ID=47113180

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020110024607A KR101418826B1 (en) 2011-03-18 2011-03-18 Cosmetic composition including herb medicine extract

Country Status (1)

Country Link
KR (1) KR101418826B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160003912A (en) * 2014-07-01 2016-01-12 주식회사 엘지생활건강 Cosmetic composition for whitening or improving the facial color containing herb extracts
CN109044962A (en) * 2018-07-31 2018-12-21 亳州市新健康科技有限公司 A kind of vaginal plugging gel and its preparation process
KR102493601B1 (en) 2022-05-19 2023-01-31 (주)유알지 Manufacturing method of composition for mist using Helichrysum Italicum flower extracted water and its composition for mist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940001125B1 (en) * 1991-03-06 1994-02-14 주식회사 태평양 Thirosinase interfering drug composition containing chrysanthemum moriflium ramat extracts
KR100361433B1 (en) * 1998-05-28 2003-01-24 주식회사 태평양 Anti-aging cosmetic compositions containing an Extract obtained from Panax ginseng
KR20070102911A (en) * 2006-04-17 2007-10-22 (주)더페이스샵코리아 A cosmetic composition for improving a skin conditon containing chamaecyparis obtusa extracts
KR100858629B1 (en) * 2007-02-28 2008-09-17 주식회사 코리아나화장품 Cosmetic Composition for increasing the Skin Energy Comprising Chamaecyparis obtusa, Pinus thunbergii and Pinus bungeana Extract

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160003912A (en) * 2014-07-01 2016-01-12 주식회사 엘지생활건강 Cosmetic composition for whitening or improving the facial color containing herb extracts
CN109044962A (en) * 2018-07-31 2018-12-21 亳州市新健康科技有限公司 A kind of vaginal plugging gel and its preparation process
KR102493601B1 (en) 2022-05-19 2023-01-31 (주)유알지 Manufacturing method of composition for mist using Helichrysum Italicum flower extracted water and its composition for mist

Also Published As

Publication number Publication date
KR101418826B1 (en) 2014-07-16

Similar Documents

Publication Publication Date Title
CN102641228B (en) Rhodiola crenulata eye cream with whitening and anti-wrinkle effects
CN106176511B (en) A kind of propolis pore cleanser nose film and its preparation method and application
KR101425031B1 (en) Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil
KR20080002279A (en) Lip cosmetic composition for atopy skin
KR102083294B1 (en) A composition for skin reproduction containing extracts of abeliophyllum distichum and extract thereof having skin reproduction effect
CN109498538B (en) Composition, cosmetic and essence with moisturizing and whitening effects and preparation method thereof
CN112043661B (en) Whitening aloe gel and preparation method thereof
CN1164254C (en) Supercritical rhodiola essence extracting process
KR20050073918A (en) Cosmetic composition comprising plant extract having anti-aging effect
CN112137921A (en) Soothing and anti-allergy composition, application thereof and soothing and anti-allergy mask
KR20120106475A (en) Functional cosmetic composition including herb medicine extract
CN102872240B (en) Compound essential oil for relaxing and activating collaterals
KR102561149B1 (en) Composition for improving skin condition comprising herb extracts mixture
CN104188808B (en) A kind of nti-freckle is dispelled yellow gel and preparation method thereof
CN111437243A (en) Wrinkle-removing and anti-aging composition, formula of anti-aging cosmetic and preparation method of anti-aging cosmetic
CN102961275A (en) Araliaceae Acanthopanax trifoliatus ethanol extract-containing skin cosmetic
KR20080111249A (en) A cosmetic composing chia seed extract
CN105342966A (en) Skin care moisturizer containing hirudo nipponia and preparation method of skin care moisturizer
CN102302426B (en) Skin-caring composition with speckle fading away and wrinkle removing effects
KR102573375B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR20230081341A (en) Shampoo for fine hair improvement with herbal extracts
CN102988266A (en) Traditional Chinese medicine shampoo containing Chinese angelica
CN106420991A (en) Skin care massage oil containing tea tree essential oil
CN106214581A (en) A kind of cosmetic composition containing black Fructus Lycii extract and disposable sleep mask
KR101077160B1 (en) Pore-minimizing cosmetic composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170627

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180423

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190214

Year of fee payment: 8